ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,700Medicare Part D Prescriptions Filled, Including Refills

Rank: 99 out of 3593

$1.46M Total Retail Price of All Prescriptions

Rank: 54 out of 3593

376 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 376 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 376 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 18,971 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

58 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 679 595 1 4
HYDROCODONE-ACETAMINOPHEN 627 507 S3 2 7
FUROSEMIDE 590 514 3 9
DONEPEZIL HCL 572 523 4 31
MIRTAZAPINE 555 526 5 64
AMLODIPINE BESYLATE 541 512 6 3
POTASSIUM CHLORIDE 513 447 7 24
LISINOPRIL 507 456 8 2
NAMENDA 470 449 9 50
SIMVASTATIN 413 341 10 1
ESCITALOPRAM OXALATE 409 347 11 71
METOPROLOL TARTRATE 401 337 12 8
WARFARIN SODIUM 357 357 13 18
GABAPENTIN 356 282 14 16
QUETIAPINE FUMARATE 356 315 14 89
TRAMADOL HCL 332 315 16 17
CITALOPRAM HBR 312 291 17 25
NOVOLOG 307 251 18 134
LANTUS 291 245 19 57
ZOLPIDEM TARTRATE 286 247 20 12
RISPERIDONE 277 237 21 83
METFORMIN HCL 256 211 22 6
NOVOLIN R 247 213 23 140
FENTANYL 207 197 S2 24 137
CLOPIDOGREL 204 183 25 30
CEFTRIAXONE 189 172 26 301
OXYCODONE-ACETAMINOPHEN 188 150 S2 27 93
ATENOLOL 184 170 28 11
PLAVIX 175 160 29 42
DIVALPROEX SODIUM 172 121 30 121
SEROQUEL 168 149 31 172
FAMOTIDINE 165 146 32 70
SERTRALINE HCL 155 145 33 28
IPRATROPIUM-ALBUTEROL 154 141 34 154
TAMSULOSIN HCL 151 144 35 33
CIPROFLOXACIN HCL 149 138 36 52
CLONIDINE HCL 143 124 37 41
HUMALOG 141 127 38 249
GLIPIZIDE 141 117 38 40
LEVOFLOXACIN 140 130 40 116
LEVETIRACETAM 139 105 41 127
LEXAPRO 123 100 42 184
LIDOCAINE HCL 118 106 43 385
CARBIDOPA-LEVODOPA 115 115 44 135
TRIAMCINOLONE ACETONIDE 114 102 45 119
METOPROLOL SUCCINATE 111 99 46 19
ALENDRONATE SODIUM 111 104 46 22
PHENYTOIN SODIUM EXTENDED 110 86 48 165
CYMBALTA 109 77 49 73
SANTYL 107 107 50 208
ISOSORBIDE MONONITRATE ER 106 99 51 61
LYRICA 105 93 52 105
BACLOFEN 105 51 52 109
CEPHALEXIN 103 90 54 150
CARVEDILOL 102 96 55 23
FLUOXETINE HCL 94 81 56 60
HYDROCHLOROTHIAZIDE 93 93 57 10
EXELON 93 92 57 123
NITROFURANTOIN MONO-MACRO 93 89 57 242
PROMETHAZINE HCL 92 86 R 60 142
RAMIPRIL 89 85 61 92
DIOVAN 87 75 62 46
MUPIROCIN 87 87 62 132
MORPHINE SULFATE ER 86 65 S2 64 108
AZITHROMYCIN 85 77 65 34
LACTULOSE 84 51 66 126
LIDODERM 83 72 67 78
PRAVASTATIN SODIUM 82 77 68 13
TRAZODONE HCL 81 63 69 53
SULFAMETHOXAZOLE-TRIMETHOPRIM 79 75 70 102
CELEBREX 78 65 71 100
GLYBURIDE 77 71 R 72 55
TRAVATAN Z 75 70 73 292
PAROXETINE HCL 74 54 74 62
POLYETHYLENE GLYCOL 3350 74 73 74 143
DIGOXIN 74 74 74 58
ALLOPURINOL 74 69 74 35
METOCLOPRAMIDE HCL 73 63 78 145
ALBUTEROL SULFATE 72 65 79 157
TORSEMIDE 72 64 79 218
ZIPRASIDONE HCL 71 51 81 398
OXYCODONE HCL 69 55 S2 82 59
ADVAIR DISKUS 67 64 83 47
BUSPIRONE HCL 67 67 83 156
IBUPROFEN 66 34 85 43
KLOR-CON M20 64 39 86 139
NYSTATIN 64 61 86 167
INSULIN SYRINGE 63 62 88 91
DILTIAZEM HCL 63 63 88 250
FINASTERIDE 62 51 90 79
SINGLE USE SWAB 62 61 90 311
ATORVASTATIN CALCIUM 60 56 92 15
AMOX TR-POTASSIUM CLAVULANATE 59 53 93 138
SPIRIVA 59 55 93 87
DIVALPROEX SODIUM ER 59 59 93 256
OXCARBAZEPINE 57 38 96 357
LATANOPROST 56 38 97 195
CARAFATE 56 56 97 427
OMEPRAZOLE 55 47 99 5
OLANZAPINE 54 40 100 198
OXYBUTYNIN CHLORIDE ER 54 46 100 175
CYCLOBENZAPRINE HCL 54 53 R 100 72
OXYBUTYNIN CHLORIDE 54 49 100 104
DOXYCYCLINE HYCLATE 53 50 104 141
FLUCONAZOLE 50 38 105 229
SPIRONOLACTONE 50 39 105 86
ROPINIROLE HCL 50 50 105 144
ABILIFY 50 11 105 162
IPRATROPIUM BROMIDE 50 50 105 210
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.